{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:00:43Z","timestamp":1787238043126,"version":"build-2736575974"},"reference-count":35,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T00:00:00Z","timestamp":1677283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Andrology"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although Klinefelter syndrome (KS) is the most frequent sex\u2010hormone disorder, there is ongoing uncertainty about the often associated sex\u2010hormone deficiency, its impact on common comorbidities, and therefore about prevention and treatment. In this study, we focus on bone loss, reported to occur in over 40% of KS patients, and the impact of testosterone replacement therapy (TRT) on this comorbidity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This single\u2010center retrospective cohort study in a tertiary hospital compared the effect of treatment with TRT to no TRT on evolution of bone mineral density (BMD) in KS patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>After a medical chart review, a total of 52 KS subjects were included in this study. BMD was measured by dual\u2010energy X\u2010ray absorptiometry (DXA) and expressed as T\u2010scores.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The subjects were divided into three groups, according to TRT. In the subgroup that only started TRT after baseline measurements (mean age 31 years), we observed significant gain in BMD T\u2010score at the lumbar spine (0.58 \u00b1 0.60,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.003; mean gain of 0.62% areal BMD per year) and total femur T\u2010score (0.24 \u00b1 0.39,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.041; mean gain of 0.25% areal BMD per year) after a mean follow\u2010up period of 7.5 years. Compared to untreated subjects, a significant difference in evolution was demonstrated at the lumbar level (+0.58 \u00b1 0.60 vs. \u22120.14 \u00b1 0.42,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.007). In untreated subjects with normal testosterone levels, a loss of BMD (\u22120.27 \u00b1 0.37,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.029; mean loss of 0.49% areal BMD per year) at the femoral neck was measured. This decline was equal to the predicted loss seen in the general male population.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>TRT results in BMD gain in patients with KS with testosterone deficiency, mainly at the lumbar spine. However, this effect is limited (0.62% per year). Patients who were not treated with TRT because of sufficient endogenous testosterone levels, showed only the predicted age\u2010related bone loss during follow\u2010up. The need for TRT in maintaining bone health in KS should be evaluated on an individual basis according to the degree of sex steroid deficiency.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/andr.13411","type":"journal-article","created":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T23:29:58Z","timestamp":1676503798000},"page":"1295-1302","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The effect of testosterone treatment on bone mineral density in Klinefelter syndrome: A retrospective cohort study"],"prefix":"10.1111","volume":"11","author":[{"given":"Stien","family":"Willems","sequence":"first","affiliation":[{"name":"Faculty of Medicine University of Leuven  Leuven Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6050-6677","authenticated-orcid":false,"given":"Karel","family":"David","sequence":"additional","affiliation":[{"name":"Department of Endocrinology University Hospitals Leuven  Leuven Belgium"},{"name":"Laboratory of Clinical and Experimental Medicine Department of Chronic Diseases and Metabolism KU Leuven  Leuven Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Decallonne","sequence":"additional","affiliation":[{"name":"Department of Endocrinology University Hospitals Leuven  Leuven Belgium"},{"name":"Laboratory of Clinical and Experimental Medicine Department of Chronic Diseases and Metabolism KU Leuven  Leuven Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Marcq","sequence":"additional","affiliation":[{"name":"Department of Endocrinology University Hospitals Leuven  Leuven Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1079-2860","authenticated-orcid":false,"given":"Leen","family":"Antonio","sequence":"additional","affiliation":[{"name":"Department of Endocrinology University Hospitals Leuven  Leuven Belgium"},{"name":"Laboratory of Clinical and Experimental Medicine Department of Chronic Diseases and Metabolism KU Leuven  Leuven Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1395-0104","authenticated-orcid":false,"given":"Dirk","family":"Vanderschueren","sequence":"additional","affiliation":[{"name":"Department of Endocrinology University Hospitals Leuven  Leuven Belgium"},{"name":"Laboratory of Clinical and Experimental Medicine Department of Chronic Diseases and Metabolism KU Leuven  Leuven Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,2,25]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1210\/er.2017\u201000212"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03350351"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14633"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.4103\/1008\u2010682X.122201"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-2-11-615"},{"key":"e_1_2_11_7_1","unstructured":"PezzaioliLC DelbarbaA MaffezzoniF FacondoP CappelliC FerlinA.Klinefelter syndrome: The altered bone.Klinefelter's Syndrome. Trends in Andrology and Sexual Medicine. Springer;2020. doi:10.1007\/978\u20103\u2010030\u201051410\u20105_16"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/andr.12909"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/gaq026"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198\u2010010\u20101354\u20107"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-51410-5_26"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40618\u2010020\u201001299\u20101"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.1995.10.6.431"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/496948"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00223\u2010022\u201000956\u20102"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE\u201022\u20100073"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.01920"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.82.8.4163"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s001980170158"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03343854"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2272"},{"issue":"2","key":"e_1_2_11_22_1","first-page":"117","article-title":"Bone mineral density in hypogonadal men remains low after long\u2010term testosterone replacement","volume":"4","author":"Ishizaka K","year":"2002","journal-title":"Asian J Androl"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198\u2010015\u20103136\u20108"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.10.6079"},{"key":"e_1_2_11_25_1","unstructured":"Hoofdstuk IV: vergoedingsvoorwaarden voor de aangenomen specialiteiten op advies van de adviserend geneesheer.RIZIV. Accessed December 20 2021.https:\/\/www.inami.fgov.be\/SiteCollectionDocuments\/liste_specialites_chapter4_20211201.pdf"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011\u20103045"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/andr.12604"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0889\u20108529(02)00058\u20100"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.6.5741"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006\u20100173"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI84137"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11154\u2010022\u201009738\u20105"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/s8756\u20103282(03)00205\u20109"},{"key":"e_1_2_11_34_1","unstructured":"Aclasta 5 mg solution for infusion.European Medicines Agency. Accessed December 20 2021.https:\/\/www.ema.europa.eu\/en\/documents\/product\u2010information\/aclasta\u2010epar\u2010product\u2010information_en.pdf"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.4103\/1008\u2010682X.173938"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnaa003"}],"container-title":["Andrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/andr.13411","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/andr.13411","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/andr.13411","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,8]],"date-time":"2023-10-08T14:46:18Z","timestamp":1696776378000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/andr.13411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,25]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1111\/andr.13411"],"URL":"https:\/\/doi.org\/10.1111\/andr.13411","archive":["Portico"],"relation":{},"ISSN":["2047-2919","2047-2927"],"issn-type":[{"value":"2047-2919","type":"print"},{"value":"2047-2927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,25]]},"assertion":[{"value":"2022-07-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-10","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}